Medina CD, Cortés LN, Vega GMT, Cruz LJ

Language: Spanish
References: 22
Page: 22-25
PDF size: 64.72 Kb.

ABSTRACT

We report the case of a 71 year-old male with the diagnosis of diffuse large cell non Hodgkin lymphoma with immunophenotype B, who presents with fever, leukocytosis, and a positive culture for Staphylococcus aureus, associated to a disseminated dermatosis characterized by erythematous macules. The biopsy reveals leukocytoclastic vasculitis. With the final diagnosis of vasculitis associated to sepsis.

REFERENCES

1. González-Gay MA, García-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001; 27: 729-49.

2. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. 1990; 33: 1065-1067.

3. Mader R, Keystone EC. Infections that cause vasculitis. Curr Opin Rheumatol 1992; 4: 35-38.

4. Doutre MS, Barete S, Ly S et al. Vasculitis cutáneas y cutaneosistémicas. Encycl Méd Chir. Dermatologie, 98-563-A-10. Editions Scientifiques et Médicales Elsevier SAS. Paris. 2004.

5. Balk RA. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations. Dis Mon 2004; 50: 168-213.

6. Marik PE, Varon J. Sepsis: state of the art. Dis Mon 2001; 47: 465-532.

7. Balk RA. Severe sepsis and septic schock definitions, epidemiology, and clinical manifestations. Crit Care Clin 2000; 16: 179-92.

8. Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States, analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29:1303-10.

9. Pizzo PA. Current concepts: Fever in immunocompromised patients. N Engl J Med 1999; 341: 893-900.

10. Giamarellou H, Antoniadou A. Infectious complications of febrile leukopenia. Infect Dis Clin North Am 2001; 15: 457-82.

11. Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin 2001; 17: 531-70.

12. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit care Med 1998; 26: 2078-86.

13. Parrillo JE, Parker MM, Natanson C. Septic shock in humans: advances in understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 1990; 113: 227-42.

14. Palavecino E. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin Lab Med 2004; 24: 403-18.

15. Menzies BE, Kourteva I. Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immunol 1998; 66: 5994-8.

16. Hotchkiss RS, Karl IE. Endothelial cell apoptosis in sepsis: A case of habeas corpus? Crit Care Med 2004; 32: 901-2.

17. Hotchkiss RS, Tinsley KW, Swanson PE et al: Endothelial cell apoptosis in sepsis. Crit Care Med 2002; 30(5 Suppl): S225-8.

18. McReady N. Use of mneumonic to find cause of leukocytoclastic vasculitis: many possible causes. Skin Allergy News 2003; 34: 48.

19. Roane DW, Griger DR. An approach to diagnosis and initial management of systemic vasculitis. Am Fam Physician 1999; 60: 1421-30.

20. Lie JT. Histopathologic specificity of systemic vasculitis. Rheum Dis Clin North Am 1995; 21: 883-909.

21. Gibson LE. Cutaneous vasculitis update. Dermatol Clin 2001; 19: 603-15.

22. Hunder G. Vasculitis: diagnosis and therapy. Am J Med 1996; 100(2A): 37S-45S.